Why 2011 Could Be a Big Year for Phar...

Why 2011 Could Be a Big Year for Pharmaceutical M&A

There are 1 comment on the Seeking Alpha story from Apr 24, 2011, titled Why 2011 Could Be a Big Year for Pharmaceutical M&A. In it, Seeking Alpha reports that:

Just a couple of weeks after Gilead Sciences announced that it would be raising the prices of its leading HIV drugs, the company issued first quarter earnings numbers that were significantly below analyst expectations.

Join the discussion below, or Read more at Seeking Alpha.

FBOMBER

Winnipeg, Canada

#1 Apr 24, 2011
Good the bastards cause as much harm as good with their poison product. I hope they go bankrupt.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Gilead Sciences Discussions

Title Updated Last By Comments
News After Trump rally, equity investors move into h... Mar '17 Retribution 6
News Federal Judge Orders State Provide Mumia Abu-Ja... Jan '17 truth hurts 1
News Fight over $1,100 hepatitis C pills awaits next... (Dec '14) Dec '14 reneir880 1
News Gilead Sciences Under Investigation for Over-Ch... (Jul '14) Jul '14 Chris 1
News FDA Panel OKs Truvada for HIV Prevention (May '12) May '14 Sheldon 6
News $1,000 hepatitis C pill a tough miracle to swallow (May '14) May '14 Hep C Veterans 1
News Divide over HIV prevention drug Truvada persists (Apr '14) Apr '14 juls 2
More from around the web